The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss


Journal article


Elizabeth M Kline, Laura M Butkovich, Joshua M Bradner, Jianjun Chang, Harris Gelbard, Val Goodfellow, W Michael Caudle, Malù G Tansey
Exp. Neurol., vol. 318, Elsevier BV, 2019 Aug, pp. 157--164


Cite

Cite

APA   Click to copy
Kline, E. M., Butkovich, L. M., Bradner, J. M., Chang, J., Gelbard, H., Goodfellow, V., … Tansey, M. G. (2019). The second generation mixed lineage kinase-3 ({MLK3}) inhibitor {CLFB-1134} protects against neurotoxin-induced nigral dopaminergic neuron loss. Exp. Neurol., 318, 157–164. https://doi.org/10.1016/j.expneurol.2019.05.002


Chicago/Turabian   Click to copy
Kline, Elizabeth M, Laura M Butkovich, Joshua M Bradner, Jianjun Chang, Harris Gelbard, Val Goodfellow, W Michael Caudle, and Malù G Tansey. “The Second Generation Mixed Lineage Kinase-3 ({MLK3}) Inhibitor {CLFB-1134} Protects against Neurotoxin-Induced Nigral Dopaminergic Neuron Loss.” Exp. Neurol. 318 (August 2019): 157–164.


MLA   Click to copy
Kline, Elizabeth M., et al. “The Second Generation Mixed Lineage Kinase-3 ({MLK3}) Inhibitor {CLFB-1134} Protects against Neurotoxin-Induced Nigral Dopaminergic Neuron Loss.” Exp. Neurol., vol. 318, Elsevier BV, Aug. 2019, pp. 157–64, doi:10.1016/j.expneurol.2019.05.002.


BibTeX   Click to copy

@article{kline2019a,
  title = {The second generation mixed lineage kinase-3 ({MLK3}) inhibitor {CLFB-1134} protects against neurotoxin-induced nigral dopaminergic neuron loss},
  year = {2019},
  month = aug,
  journal = {Exp. Neurol.},
  pages = {157--164},
  publisher = {Elsevier BV},
  volume = {318},
  doi = {10.1016/j.expneurol.2019.05.002},
  author = {Kline, Elizabeth M and Butkovich, Laura M and Bradner, Joshua M and Chang, Jianjun and Gelbard, Harris and Goodfellow, Val and Caudle, W Michael and Tansey, Malù G},
  month_numeric = {8}
}